Lilly jumps in with Vir, GSK on antibody drug combo against Covid
January 27, 2021 at 16:04 PM EST
Vir's stock soared for the second day in a row, this time because it and partner GlaxoSmithKline disclosed a trial combining their monoclonal antibody with Lilly's authorized Covid-19 treatment.
